加载中
NYSEConsumer DefensiveHousehold & Personal Products
最新数据
US$17.5901
−US$0.2399 · -1.35%
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
常规交易时段
US$17.615
−US$0.215 · -1.21%
盘中时间采用ET。市场数据可能有所延迟。
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
日内区间
当前US$17.615
52周区间
当前US$17.615
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
买入
估值
84
深度低估
情绪
54
多空交织
风险
23
中等风险
动量
49
中性
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
日内区间
当前US$17.615
52周区间
当前US$17.615
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 151.24亿 USD | 154.55亿 USD | 154.44亿 USD | 149.5亿 USD | 150.54亿 USD |
| 销货成本 | 63.32亿 USD | 64.96亿 USD | 68.01亿 USD | 66.65亿 USD | 66.35亿 USD |
| 毛利 | 87.92亿 USD | 89.59亿 USD | 86.43亿 USD | 82.85亿 USD | 84.19亿 USD |
| 研究与开发 | 3.82亿 USD | — | — | — | — |
| 销售、一般及管理费用 | 60.88亿 USD | 60.27亿 USD | 61.41亿 USD | 56.33亿 USD | 54.84亿 USD |
| 营业费用 | 60.88亿 USD | 71.18亿 USD | 61.31亿 USD | 56.1亿 USD | 54.99亿 USD |
| 利息收入 | — | 5300万 USD | 1.08亿 USD | — | — |
| 利息支出 | 3.79亿 USD | 4.31亿 USD | 3.58亿 USD | — | — |
| 折旧和摊销 | 5.57亿 USD | 6.22亿 USD | 6.27亿 USD | 6.44亿 USD | 7.31亿 USD |
| 营业利润 | 27.04亿 USD | 18.41亿 USD | 25.12亿 USD | 26.75亿 USD | 29.2亿 USD |
| 净利润 | 14.7亿 USD | 10.3亿 USD | 16.64亿 USD | 20.64亿 USD | 20.78亿 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$19.50
上涨空间 10.70%报告持有此股票敞口的交易所交易基金。
State Street SPDR S&P 500 ETF1557.T656.37亿0.05%130.34万亿 JPY0.09%JP¥122,950+0.08%
Vanguard Morningstar Total Stock Market ETFVTI11.52亿0.05%2.3万亿 USD0.03%US$380.76-0.21%
Vanguard S&P 500 ETFVOO9.63亿0.05%1.8万亿 USD0.03%US$714.03-0.15%
Vanguard Morningstar Mid-Cap ETFVO7.84亿0.35%2264亿 USD0.03%US$80.58-0.42%
iShares Core S&P 500 ETFIVV4.56亿0.05%8964.4亿 USD0.03%US$780.25-0.15%
State Street SPDR S&P 500 ETFSPY4.14亿0.05%8216.79亿 USD0.09%US$776.78-0.17%
Vanguard Morningstar Value ETFVTV3.46亿0.13%2624亿 USD0.03%US$220.44-0.45%
State Street SPDR S&P Dividend ETFSDY3.1亿1.49%206.92亿 USD0.35%US$150.33-0.03%State Street SPDR S&P 500 ETF1557.TVanguard Morningstar Total Stock Market ETFVTIVanguard S&P 500 ETFVOOVanguard Morningstar Mid-Cap ETFVOiShares Core S&P 500 ETFIVVState Street SPDR S&P 500 ETFSPYVanguard Morningstar Value ETFVTVState Street SPDR S&P Dividend ETFSDYAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
